ALPHAMAB ONCOLO.DL-000002 Working Capital to Net Assets Ratio
ALPHAMAB ONCOLO.DL-000002 working capital to net assets ratio. ALPHAMAB ONCOLO.DL-000002 (3NK) has a Working Capital to Net Assets ratio of 76.7% as of December 2025. Working capital of €1.31 Billion (current assets of €1.59 Billion minus current liabilities of €280.85 Million) is measured against net assets of €1.71 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of ALPHAMAB ONCOLO.DL-000002 to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of ALPHAMAB ONCOLO.DL-000002 (2021–2025)
Working capital to net assets ratio of ALPHAMAB ONCOLO.DL-000002 from 2021 to 2025. This chart shows how ALPHAMAB ONCOLO.DL-000002's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 76.7%, reflecting working capital of €1.31 Billion against net assets of €1.71 Billion EUR. See ALPHAMAB ONCOLO.DL-000002 defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
ALPHAMAB ONCOLO.DL-000002 Working Capital to Net Assets Ratio by Year (2021–2025)
ALPHAMAB ONCOLO.DL-000002 working capital to net assets ratio by year from 2021 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for ALPHAMAB ONCOLO.DL-000002 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 3NK asset base.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 76.7% | €1.31 Billion | €1.71 Billion | €1.59 Billion | €280.85 Million | ▼ -2.8 pp |
| 2024 | 79.6% | €1.46 Billion | €1.83 Billion | €1.71 Billion | €254.04 Million | ▲ +2.3 pp |
| 2023 | 77.2% | €1.29 Billion | €1.67 Billion | €1.56 Billion | €266.84 Million | ▲ +6.0 pp |
| 2022 | 71.2% | €1.11 Billion | €1.56 Billion | €1.49 Billion | €384.91 Million | ▼ -7.9 pp |
| 2021 | 79.1% | €1.48 Billion | €1.87 Billion | €2.12 Billion | €637.26 Million | — |